Travere Therapeutics, Inc. Annual Costs and Expenses in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Travere Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2010 to 2023.
  • Travere Therapeutics, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $119M, a 8.2% decline year-over-year.
  • Travere Therapeutics, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $561M, a 9.93% increase year-over-year.
  • Travere Therapeutics, Inc. annual Costs and Expenses for 2023 was $533M, a 24.3% increase from 2022.
  • Travere Therapeutics, Inc. annual Costs and Expenses for 2022 was $429M, a 29.6% increase from 2021.
  • Travere Therapeutics, Inc. annual Costs and Expenses for 2021 was $331M, a 11.5% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $533M +$104M +24.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $429M +$98M +29.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $331M -$43.2M -11.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $374M +$61.8M +19.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $313M +$68.4M +28% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $244M +$35.6M +17% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $209M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2011 $14.8K* -$8.2K Mar 2, 2011 Feb 29, 2012 10-K 2012-05-24
2010 $23K* Mar 1, 2010 Feb 28, 2011 10-K 2012-05-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.